Management of suppuration in regional lymph nodes secondary to BCG vaccination. 1991

S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
SSK Tepecik Teaching Hospital, IZMIR-Turkey.

We describe 50 patients with suppurative regional lymphadenitis following intradermal BCG vaccination. For non-drained suppurations we performed needle aspiration in twenty-three patients (aspiration group). Of the remaining 27 patients (drainage group) 16 had spontaneous drainage and 11 incisional drainage. In the drainage group, 17 patients were followed up conservatively. Ten patients from the drainage group and 3 patients from the aspiration group (drained after needle aspiration) accepted total surgical excision to terminate the drainage. Twenty of twenty-three patients in the aspiration group recovered after needle aspiration. Average period of cessation of drainage and healing of wound was 7.5 weeks in patients with drainage (spontaneous and incisional). Healing was complete after total surgical excision of draining suppurations in all of 11 patients. We concluded that simple needle aspiration was sufficient for the treatment of suppurating but non-drained BCG lymphadenitis. For suppurating lymph nodes that were surgically (not recommended) or spontaneously drained, a more invasive procedure, total surgical excision, was proposed to terminate the long and disturbing drainage period.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008199 Lymphadenitis Inflammation of the lymph nodes. Adenitis,Adenitides,Lymphadenitides
D004322 Drainage The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D013492 Suppuration A pathologic process consisting in the formation of pus. Pus

Related Publications

S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
February 1956, American review of tuberculosis,
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
January 1970, Plucne bolesti i tuberkuloza,
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
January 1970, Plucne bolesti i tuberkuloza,
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
July 1956, Lyon medical,
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
November 1963, Gyermekgyogyaszat : az Orvosegeszsegugyi Szakszervezet Gyermekorvos Szakcsoportjanak folyoirata = Pediatriia,
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
April 1989, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes,
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
June 1950, American journal of diseases of children (1911),
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
April 1973, Orvosi hetilap,
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
November 2003, The British journal of dermatology,
S Caglayan, and A Arikan, and I Yaprak, and K Aksoz, and S Kansoy
May 1964, Orvosi hetilap,
Copied contents to your clipboard!